These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26403465)

  • 1. Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
    Sundell K; Jagannathan P; Huang L; Bigira V; Kapisi J; Kakuru MM; Savic R; Kamya MR; Dorsey G; Aweeka F
    Malar J; 2015 Sep; 14():368. PubMed ID: 26403465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.
    Permala J; Tarning J; Nosten F; White NJ; Karlsson MO; Bergstrand M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
    Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR
    Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
    Kamya MR; Kapisi J; Bigira V; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Kakuru A; Aweeka FT; Huang L; Jagannathan P; Achan J; Havlir DV; Rosenthal PJ; Dorsey G
    AIDS; 2014 Nov; 28(18):2701-9. PubMed ID: 25493596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
    Creek DJ; Bigira V; McCormack S; Arinaitwe E; Wanzira H; Kakuru A; Tappero JW; Sandison TG; Lindegardh N; Nosten F; Aweeka FT; Parikh S
    J Infect Dis; 2013 Jun; 207(11):1646-54. PubMed ID: 23447696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
    Zongo I; Somé FA; Somda SA; Parikh S; Rouamba N; Rosenthal PJ; Tarning J; Lindegardh N; Nosten F; Ouédraogo JB
    PLoS One; 2014; 9(8):e103200. PubMed ID: 25133389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.
    Kajubi R; Huang L; Jagannathan P; Chamankhah N; Were M; Ruel T; Koss CA; Kakuru A; Mwebaza N; Kamya M; Havlir D; Dorsey G; Rosenthal PJ; Aweeka FT
    Clin Pharmacol Ther; 2017 Sep; 102(3):520-528. PubMed ID: 28187497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Hughes E; Wallender E; Kajubi R; Jagannathan P; Ochieng T; Kakuru A; Kamya MR; Clark TD; Rosenthal PJ; Dorsey G; Aweeka F; Savic RM
    Clin Infect Dis; 2022 Aug; 75(3):406-415. PubMed ID: 34864925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
    Bigira V; Kapisi J; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Osterbauer B; Aweeka FT; Huang L; Achan J; Havlir DV; Rosenthal PJ; Kamya MR; Dorsey G
    PLoS Med; 2014 Aug; 11(8):e1001689. PubMed ID: 25093754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
    Assefa DG; Zeleke ED; Bekele D; Tesfahunei HA; Getachew E; Joseph M; Manyazewal T
    Malar J; 2021 Apr; 20(1):174. PubMed ID: 33794897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz.
    Wallender E; Vucicevic K; Jagannathan P; Huang L; Natureeba P; Kakuru A; Muhindo M; Nakalembe M; Havlir D; Kamya M; Aweeka F; Dorsey G; Rosenthal PJ; Savic RM
    J Infect Dis; 2018 Mar; 217(6):964-972. PubMed ID: 29272443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.
    Kapisi J; Bigira V; Clark T; Kinara S; Mwangwa F; Achan J; Kamya M; Soremekun S; Dorsey G
    Malar J; 2015 Feb; 14():53. PubMed ID: 25652127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
    Sambol NC; Tappero JW; Arinaitwe E; Parikh S
    PLoS One; 2016; 11(5):e0154623. PubMed ID: 27182702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.
    Whalen ME; Kajubi R; Chamankhah N; Huang L; Orukan F; Wallender E; Kamya MR; Dorsey G; Jagannathan P; Rosenthal PJ; Mwebaza N; Aweeka FT
    Clin Pharmacol Ther; 2019 Dec; 106(6):1310-1318. PubMed ID: 31173649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.
    Kwambai TK; Dhabangi A; Idro R; Opoka R; Kariuki S; Samuels AM; Desai M; van Hensbroek MB; John CC; Robberstad B; Wang D; Phiri K; Ter Kuile FO
    Trials; 2018 Nov; 19(1):610. PubMed ID: 30400934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
    Moore BR; Benjamin JM; Salman S; Griffin S; Ginny E; Page-Sharp M; Robinson LJ; Siba P; Batty KT; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5784-94. PubMed ID: 25049242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Field Trial to Assess the Safety and Efficacy of Dihydroartemisinin-Piperaquine for Seasonal Malaria Chemoprevention in School-Aged Children in Bandiagara, Mali.
    Traore K; Coulibaly D; Kone AK; Guindo B; Traore S; Kouriba K; Djimde M; Thera MA
    J Infect Dis; 2024 Jan; 229(1):189-197. PubMed ID: 37682871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.